Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo-Reference-Cited by-同舟云学术

Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo

Published:2013-01-04 Issue:2 Volume:7 Page:994-1005
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Meng Huan¹,Mai Wilson X.¹,Zhang Haiyuan¹,Xue Min¹,Xia Tian¹,Lin Sijie¹,Wang Xiang¹,Zhao Yang¹,Ji Zhaoxia¹,Zink Jeffrey I.¹,Nel Andre E.¹

Affiliation:

1. Division of NanoMedicine, Department of Medicine, ‡Department of Chemistry & Biochemistry, and §California NanoSystems Institute, University of California, Los Angeles

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/nn3044066

Reference46 articles.

1. Mechanisms of Cancer Drug Resistance

2. Multi-functional nanocarriers to overcome tumor drug resistance

3. Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer

4. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance

Cited by 535 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision arrows: Navigating breast cancer with nanotechnology siRNA;International Journal of Pharmaceutics;2024-09

2. Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress;Molecular Therapy - Nucleic Acids;2024-09

3. Advances and prospects of RNA delivery nanoplatforms for cancer therapy;Acta Pharmaceutica Sinica B;2024-09

4. Combination eEF2K gene and drug delivery for treatment of breast cancer;Journal of Bioactive and Compatible Polymers;2024-08-02

5. Using nanotechnology to progress the utilization of marine natural products in combating multidrug resistance in cancer: A prospective strategy;Journal of Biochemical and Molecular Toxicology;2024-05-20